1. Home
  2. ICL vs DVA Comparison

ICL vs DVA Comparison

Compare ICL & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICL Group Ltd.

ICL

ICL Group Ltd.

HOLD

Current Price

$5.36

Market Cap

6.5B

Sector

Industrials

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$150.71

Market Cap

10.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICL
DVA
Founded
1968
1994
Country
Israel
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Misc Health and Biotechnology Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
10.1B
IPO Year
2001
2002

Fundamental Metrics

Financial Performance
Metric
ICL
DVA
Price
$5.36
$150.71
Analyst Decision
Hold
Hold
Analyst Count
2
4
Target Price
$6.10
$156.75
AVG Volume (30 Days)
1.6M
797.3K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
3.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
9.84
Revenue
N/A
$13,643,069,000.00
Revenue This Year
$6.04
$3.80
Revenue Next Year
$3.27
$3.04
P/E Ratio
$31.41
$15.57
Revenue Growth
N/A
6.46
52 Week Low
$4.76
$101.00
52 Week High
$7.35
$159.42

Technical Indicators

Market Signals
Indicator
ICL
DVA
Relative Strength Index (RSI) 52.99 57.20
Support Level $5.26 $146.00
Resistance Level $5.78 $150.69
Average True Range (ATR) 0.12 4.81
MACD 0.04 -1.40
Stochastic Oscillator 77.27 34.35

Price Performance

Historical Comparison
ICL
DVA

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Share on Social Networks: